Register for SOSV HAX Investor Showcase – April 1, 2026
Post
Mar 05, 2026

IndieBio is Now SOSV NY & SOSV SF, Underscoring SOSV’s Leadership in Deep Tech

In 2015, SOSV opened IndieBio San Francisco, Silicon Valley’s first biotech program that offered bio-labs as well as pre-seed investment to scientists ready to launch startups. IndieBio took the world by storm and biotech investing surged. In 2020, SOSV opened a second IndieBio in New York City.  Between 2015 and 2025, IndieBio’s 310 graduates raised […]

Recent news

Type
Trends
Programs
Category
Post Mar 09, 2026

Avalo.ai: The David & Goliath of Large Genomic Models 

Of all the languages an AI could master, without a doubt one of the hardest and most impactful is the genetic language of life itself.  So while our world is enthralled with the ability of LLMs to understand all human languages and programming languages, these LLMs also now understand the symbolic languages of math and musical […]

Post Mar 02, 2026

Meet Avra van der Zee, SOSV’s New General Partner

When SOSV and the New Jersey Economic Development Authority (NJEDA) announced a $50 million co-investment to build a new global headquarters for SOSV’s HAX in the heart of Newark in 2022, we knew the stakes were high. But HAX has just the right team to help early stage founders scale their product development and get to market, […]

Post Feb 27, 2026

🎥 Navigating the Realities of Energy Scale-Up with Dr. Barbara Burger, “Godmother of Energy Investing”

📍 Broadcast live from our SOSV NY event space in Manhattan, SOSV Deep Tech LIVE is our monthly video podcast series exploring the frontiers of deep tech with leading founders, researchers, and technologists.  On the latest installment of SOSV Deep Tech Live (aired February 26, 2026), Dr. Susan Schofer (SOSV HAX) joined Dr. Barbara Burger to […]

Post Feb 26, 2026

HAX’s Deep Tech Showcase During NYC Deep Tech Week

Investors! Join HAX in New York on April 1 for Investor Showcase during New York Deep Tech Week featuring 20+ startups ranging from plasma physics to advanced chemistry to critical minerals, and more.

Press Release Feb 26, 2026

HAX, One of NJEDA’s Strategic Innovation Centers, Ignites Tech-Based Economic Development

Back in 2018, Governor Phil Murphy set out to strengthen New Jersey as a home for breakthrough innovation by building new Strategic Innovation Centers (SIC), led by the New Jersey Economic Development Authority (NJEDA). Three years later, the NJEDA spotted an opportunity: an RFP from SOSV to select the global headquarters for its hard-tech program, HAX. […]

Triangle Business Journal Feb 19, 2026

Ten63 Therapeutics Closes Strategic Financing for AI Drug Discovery

SOSV portfolio company and graduate of the IndieBio progrmam, Ten63 Therapeutics recently announced that it added strategic investment from new investors Chugai Venture Fund and the Gates Foundation, bringing the company’s total funding to over $45M. The company is an advanced AI drug-discovery company and with this increased funding they plan to fuel the advancement […]

Glossy Feb 04, 2026

The Wellness Categories Po Bronson Is Eyeing (& Avoiding) in 2026

SOSV General Partner Po Bronson alongside other leading wellness industry investors spoke to Glossy about about what’s in and out when it comes to 2026 wellness investments. Fiber Is In: There’s a growing wave of research unpacking the bioactivity of specific lipids and fibers, and that shift is beginning to transform how we think about […]

Bloomberg Feb 03, 2026

Duncan Turner Talks About How Trump’s Project Vault Impacts Critical Mineral Startups

Yesterday, Trump announced a $12B critical minerals stockpile program (“Project Vault”) to procure and store critical minerals in the U.S. SOSV General Partner Duncan Turner told Bloomberg that the move signals a meaningful push to build a domestic critical-minerals supply chain – opening the door for next-gen mining, processing, and refining technologies in a sector […]

Post Feb 02, 2026

IndieBio New York’s Investor Showcase – March 11, 2026

Investors! Join IndieBio in New York on March 11 for Investor Showcase featuring 15+ startups across climate and health.

Post Jan 29, 2026

Q&A: HyIvy, Reclaiming Pelvic Health

In medtech, clinical adoption speed separates winners from the pack. HyIvy Health has the type of traction a Series B company would be jealous of. So while the venture market has been slow to understand how massive a market women’s health is, there is a huge unmet need that Rachel and team have hit on. […]